Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States

Journal of Clinical Oncology

Volumn 34, Issue 2, 2016, Pages 169-178

  Murphy, Colin T ^a   Galloway, Thomas J ^a   Handorf, Elizabeth A ^a   Egleston, Brian L ^a   Wang, Lora S ^a   Mehra, Ranee ^a   Flieder, Douglas B ^a   Ridge, John A ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; THERAPY DELAY; TIME TO TREATMENT; TONGUE CANCER; UNITED STATES; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; FACTUAL DATABASE; HEAD AND NECK NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; UNITED STATES;

EID: 84954210296     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.5906     Document Type: Article

References (49)

1. Murphy CT, Galloway TJ, Handorf EA, et al: Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database. Cancer 121:1204-1213, 2015
2. Sher DJ, Neville BA, Chen AB, et al: Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: A SEERMedicare analysis. Int J Radiat Oncol Biol Phys 81: e197-e206, 2011
3. Hillner BE, Tosteson AN, Song Y, et al: Growth in the use of PET for six cancer types after coverage by Medicare: Additive or replacement. J Am Coll Radiol 9:33-41, 2012
4. Smith BD, Haffty BG, Wilson LD, et al: The future of radiation oncology in the United States from 2010 to 2020: Will supply keep pace with demand. J Clin Oncol 28:5160-5165, 2010
5. Institute of Medicine: Crossing the quality chasm: A new health system for the 21st century. http://www.iom.edu/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the- 21st-Century.aspx
6. Bilimoria KY, Ko CY, Tomlinson JS, et al:Wait times for cancer surgery in the United States: Trends and predictors of delays. Ann Surg 253:779-785, 2011
7. Waaijer A, Terhaard CHJ, Dehnad H, et al: Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol 66:271-276, 2003
8. Jensen AR, Nellemann HM, Overgaard J: Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 84:5-10, 2007
9. Pulte D, Brenner H: Changes in survival in head and neck cancers in the late 20th and early 21st century: A period analysis. Oncologist 15:994-1001, 2010
10. Bilimoria KY, Stewart AK, Winchester DP, et al: The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15:683-690, 2008
11. Mell LK, Dignam JJ, Salama JK, et al: Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28:15-20, 2010
12. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343-346, 1996
13. Le Blanc M, Crowley J: Relative risk trees for censored survival data. Biometrics 48:411-425, 1992
14. Harrell FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer Science and Business Media, 2013
15. 18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: A multicenter prospective study. J Clin Oncol 28:1190-1195, 2010
16. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data-MACHNC collaborative group.meta-analysis of chemotherapy on head and neck cancer. Lancet 355: 949-955, 2000
17. Nutting CM, Morden JP, Harrington KJ, et al: Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127-136, 2011
18. Chen AY, Fedewa S, Pavluck A, et al: Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer 116: 4744-4752, 2010
19. Chen AY, Pavluck A, Halpern M, et al: Impact of treating facilities' volume on survival for early-stage laryngeal cancer. Head Neck 31:1137-1143, 2009
20. Birkmeyer JD, Siewers AE, Finlayson EVA, et al: Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137, 2002
21. Ang KK, Trotti A, Brown BW, et al: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:571-578, 2001
22. Primdahl H, Nielsen AL, Larsen S, et al: Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA. Acta Oncol 45:156-161, 2006
23. Toustrup K, Lambertsen K, Birke-Sørensen H, et al: Reduction in waiting time for diagnosis and treatment of head and neck cancer: A fast track study. Acta Oncol 50:636-641, 2011
24. Sorensen JR, Johansen J, Gano L, et al: A "package solution" fast track program can reduce the diagnostic waiting time in head and neck cancer. Eur Arch Otorhinolaryngol 271:1163-1170, 2014
25. Lyhne NM, Christensen A, Alanin MC, et al: Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer 49:1627-1633, 2013
26. Fox Chase Cancer Center: Rapid Access Appointments. https://www.fccc.edu/myFoxChase/patients/enrollment/index.html
27. Merino OR, Lindberg RD, Fletcher GH: An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40:145-151, 1977
28. Leemans CR, Tiwari R, Nauta JJ, et al: Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71:452-456, 1993
29. Leemans CR, Tiwari R, Nauta JJ, et al: Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73: 187-190, 1994
30. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
31. O'Sullivan B, Huang SH, Siu LL, et al: Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31:543-550, 2013
32. Kowalski LP, Carvalho AL: Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol 37:94-98, 2001
33. Crawford SC, Davis JA, Siddiqui NA, et al: The waiting time paradox: Population-based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 325:196, 2002
34. Comber H, Cronin DP, Deady S, et al: Delays in treatment in the cancer services: Impact on cancer stage and survival. Ir Med J 98:238-239, 2005
35. Wildt J, Bundgaard T, Bentzen SM: Delay in the diagnosis of oral squamous cell carcinoma. Clin Otolaryngol Allied Sci 20:21-25, 1995
36. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65:5-29, 2015
37. Wuthrick EJ, Zhang Q, Machtay M, et al: Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol 33:156-164, 2015
38. Tromp DM, Brouha XDR, Hordijk G-J, et al: Patient factors associated with delay in primary care among patients with head and neck carcinoma: A case-series analysis. Fam Pract 22:554-559, 2005
39. Brouha X, Tromp D, Hordijk G-J, et al: Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol 125:552-556, 2005
40. Brouha XDR, Tromp DM, Hordijk G-J, et al: Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck 27:939-945, 2005
41. Christophe V, Leroy T, Seillier M, et al: Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA). BMJ Open 4:e005286, 2014
42. Carvalho AL, Pintos J, Schlecht NF, et al: Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 128:313-318, 2002
43. Teppo H, Alho OP: Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol 45:692-695, 2009
44. Teppo H, Koivunen P, Hyrynkangas K, et al: Diagnostic delays in laryngeal carcinoma: Professional diagnostic delay is a strong independent predictor of survival. Head Neck 25:389-394, 2003
45. Brouha XDR, Tromp DM, Koole R, et al: Professional delay in head and neck cancer patients: Analysis of the diagnostic pathway. Oral Oncol 43: 551-556, 2007
46. Seoane J, Takkouche B, Varela-Centelles P, et al: Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis. Clin Otolaryngol 37:99-106, 2012
47. Albano JD, Ward E, Jemal A, et al: Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99:1384-1394, 2007
48. Shavers VL, Harlan LC, Winn D, et al: Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev 22:25-38, 2003
49. Ward E, Jemal A, Cokkinides V, et al: Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54:78-93, 2004